Article Details
Retrieved on: 2022-11-29 06:46:54
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
British drug discovery company C4X Discovery said AstraZeneca had signed a license worth up USD 402 million to develop an oral therapy for the ...
Article found on: bwhealthcareworld.businessworld.in
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here